A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Negative Driver Genes (IVO BRAIN)
Clinical trial NCT06684873 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06684873
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-02
- Primary completion
- 2027-12-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.